Drug recall · May 1, 2013
GLIMEPIRIDE TABLETS USP recall
Why: Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.
- Lots / codes
Lot #: C0671212A, Exp 12/14
- Quantity
- 10,373 bottles
- Company
- Qualitest Pharmaceuticals, Huntsville, AL
- Distribution
- Nationwide
- Initiated
- April 19, 2013 · Voluntary: Firm initiated
- Classified
- April 25, 2013
- Reported
- May 1, 2013
- Ended
- January 13, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glimepiride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.